Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atai Life Sciences N.V.
(NQ:
ATAI
)
1.250
+0.060 (+5.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 24, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
960,258
Open
1.200
Bid (Size)
1.240 (5)
Ask (Size)
1.250 (31)
Prev. Close
1.190
Today's Range
1.180 - 1.260
52wk Range
1.140 - 5.600
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
GH Research, Cybin Among Top Psychedelic Movers Of Today
March 24, 2023
Via
Benzinga
Atai Life Sciences Hopes Hercules Can Help 'Sustain' Operations Until 2026
March 24, 2023
Biopharma company Atai Life Sciences' (NASDAQ: ATAI) fourth quarter and full year 2022 consolidated financial results show:
Via
Benzinga
Performance
YTD
-52.83%
-52.83%
1 Month
-26.47%
-26.47%
3 Month
-47.70%
-47.70%
6 Month
-60.19%
-60.19%
1 Year
-75.35%
-75.35%
More News
Read More
atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights
March 24, 2023
From
atai Life Sciences
Via
Globe NewsWire
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
March 23, 2023
Via
Benzinga
The Latest Analyst Ratings for ATAI Life Sciences
March 07, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 22, 2023
March 22, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 21, 2023
March 21, 2023
Via
Benzinga
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion
March 21, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 20, 2023
March 20, 2023
Via
Benzinga
An Update On The Performance Of The 7 Largest Psychedelic Stocks
March 19, 2023
Via
Talk Markets
The "Rags-To-Riches" Portfolio: An Update
March 18, 2023
Via
Talk Markets
Psychedelic Stock Gainers And Losers From March 17, 2023
March 17, 2023
Via
Benzinga
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
March 16, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
March 15, 2023
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
March 14, 2023
Via
Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
March 13, 2023
Via
Benzinga
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
March 13, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 14, 2023
Via
Benzinga
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
March 13, 2023
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
March 10, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
March 09, 2023
Via
Benzinga
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
March 08, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 07, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
March 06, 2023
Via
Benzinga
Atai Update: Ketamine Trials Are Ongoing, Company Cuts 30% Workforce
March 06, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.